Mark Donnelly joined Baird Capital in 2022. He oversees the firm’s investments in Tellius, Cala Health and OncoHealth. Prior to joining Baird Capital, Mark was a Managing Director and head of origination at Runway Growth Capital where he led the firm’s new investment activities in the technology and healthcare IT verticals. Before Runway, Mark was a principal with Beringea, where he focused on investments in mid-stage technology and services companies in the U.S. and U.K. Mark was previously a member of the investment teams at private equity firms The Riverside Company and DW Healthcare Partners. He began his career in management consulting at Bain & Company. Mark received a B.S.E. in industrial & operations engineering from the University of Michigan and an MBA from the University of Chicago Booth School of Business.